Tytuł pozycji:
A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1–4, as a single dose and multiple doses in patients with solid malignancies
-
Tytuł:
-
A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1–4, as a single dose and multiple doses in patients with solid malignancies
-
Autorzy:
-
Yamamoto, Noboru
Ryoo, Baek-Yeol
Keam, Bhumsuk
Kudo, Masatoshi
Lin, Chia-Chi
Kunieda, Futoshi
Ball, Howard A.
Moran, Diarmuid
Komatsu, Kanji
Takeda, Kentaro
Fukuda, Musashi
Furuse, Junji
Morita, Satoshi
Doi, Toshihiko
-
Źródło:
-
Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 38(2):445-456
-